Recombinant human erythropoietin for autologous blood donation: effects on perioperative red-blood-cell and serum erythropoietin production
- 28 March 1992
- journal article
- Published by Elsevier in The Lancet
- Vol. 339 (8796) , 773-775
- https://doi.org/10.1016/0140-6736(92)91895-f
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Accelerated erythropoiesis: the hidden benefit of autologous donationTransfusion, 1990
- Erythropoietin for the Treatment of Porphyria Cutanea Tarda in a Patient on Long-Term HemodialysisNew England Journal of Medicine, 1990
- Detection of Antibody to Hepatitis C Virus in Prospectively Followed Transfusion Recipients with Acute and Chronic Non-A, Non-B HepatitisNew England Journal of Medicine, 1989
- Increased Preoperative Collection of Autologous Blood with Recombinant Human Erythropoietin TherapyNew England Journal of Medicine, 1989
- Autologous blood donations prior to elective cardiac surgery. Safety and effect on subsequent blood usePublished by American Medical Association (AMA) ,1989
- ERYTHROPOIETIN AND AUTOLOGOUS BLOOD DONATIONThe Lancet, 1989
- Prevention of transmission of human T‐lymphotropic virus type 1 (HTLV‐1) through transfusion, by donor screening with antibody to the virus One‐year experienceTransfusion, 1989
- Effect of repeated whole blood donations on serum immunoreactive erythropoietin levels in autologous donorsJAMA, 1988
- Isolation and characterization of genomic and cDNA clones of human erythropoietinNature, 1985
- The Natural History of Alloimmunization to PlateletsTransfusion, 1978